Optimisation of chemotherapy in the era of immunotherapy
- PMID: 30361267
- DOI: 10.1183/13993003.01698-2018
Optimisation of chemotherapy in the era of immunotherapy
Conflict of interest statement
Conflict of interest: R. Boosman has nothing to disclose. Conflict of interest: J.A. Burgers reports advisory board work for Roche, Boehringer Ingelheim and AstraZeneca, outside the submitted work.
Comment on
-
Renal impairment during pemetrexed maintenance in patients with advanced nonsmall cell lung cancer: a cohort study.Eur Respir J. 2018 Oct 25;52(4):1800884. doi: 10.1183/13993003.00884-2018. Print 2018 Oct. Eur Respir J. 2018. PMID: 30139775
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical